Celularity Inc.
CELU CELUWCIK 0001752828
Revenue (TTM)
$31.74M
−51.0% YoY
FY Apr 2026
Net Income (TTM)
−$83.45M
−58.4% YoY
FY Apr 2026
EPS Diluted (TTM)
−$3.47
−36.0% YoY
FY Apr 2026
Gross Margin
3.7%
FY Apr 2026
Operating Margin
-160.0%
FY Apr 2026
Net Margin
-262.9%
FY Apr 2026
Free Cash Flow (TTM)
−$59.83M
FY Apr 2026
Cash
$6.18M
FY Apr 2026
Total Debt
$34.25M
FY Apr 2026
Shares Outstanding
28.95M sh
FY Apr 2026